Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bernstein

Showing results (261-270 of 300) with videos related to

Pageof 30
Sort By:
Neuro-Oncology Advances|April 7, 2022
Multiplicity does not significantly affect outcomes in brain metastasis patients treated with surgeryKaiyun Yang, Enrique Gutiérrez-Valencia, Alexander P Landry, et al.
Journal of Neuro-Oncology|May 10, 2023
Anatomical and surgical characteristics correlate with pachymeningeal failure in patients with brain metastases after neurosurgical resection and adjuvant stereotactic radiosurgeryAristotelis Kalyvas, Enrique Gutierrez-Valencia, Ruth Lau, et al.
Neuro-Oncology|September 29, 2018
Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed doseFabio Y Moraes, Jeff Winter, Eshetu G Atenafu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology groupDavid Ebb, Paul Meyers, Holcombe Grier, et al.
Journal of Neuro-Oncology|January 29, 2022
Postoperative CT scans after resection of brain metastases: neurosurgical routine or added value?Kaiyun Yang, Alexander P Landry, Majid Aljoghaiman, et al.
Current Oncology (Toronto, Ont.)|January 22, 2021
Clinicopathologic and Treatment Features of Long-Term Surviving Brain Metastasis PatientsArchya Dasgupta, Jayson Co, Jeff Winter, et al.
Paediatrics & Child Health|January 15, 2014
Social paediatrics: From 'lip service' to the health and well-being of Canada's children and youthDenis Daneman, James Kellner, Mark Bernstein, et al.
Neurosurgery|January 4, 2022
Importance of Cobalt-60 Dose Rate and Biologically Effective Dose on Local Control for Intracranial Meningiomas Treated With Stereotactic RadiosurgeryMichael Huo, Melanie Rose, Monique van Prooijen, et al.
Neuro-Oncology|January 29, 2014
Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomasNesrin Sabha, Christiane B Knobbe, Majula Maganti, et al.
Neurosurgery|April 14, 2025
Neoadjuvant Stereotactic Radiosurgery for Large Brain Metastases: An International, Multicenter, Single-Arm Phase II TrialRanda Higazy, Dianna Li, Ruth Lau, et al.
Pageof 30

Showing results (261-270 of 300) with videos related to

Sort By:
Pageof 30
Neuro-Oncology Advances|April 7, 2022
Multiplicity does not significantly affect outcomes in brain metastasis patients treated with surgeryKaiyun Yang, Enrique Gutiérrez-Valencia, Alexander P Landry, et al.
Journal of Neuro-Oncology|May 10, 2023
Anatomical and surgical characteristics correlate with pachymeningeal failure in patients with brain metastases after neurosurgical resection and adjuvant stereotactic radiosurgeryAristotelis Kalyvas, Enrique Gutierrez-Valencia, Ruth Lau, et al.
Neuro-Oncology|September 29, 2018
Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed doseFabio Y Moraes, Jeff Winter, Eshetu G Atenafu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology groupDavid Ebb, Paul Meyers, Holcombe Grier, et al.
Journal of Neuro-Oncology|January 29, 2022
Postoperative CT scans after resection of brain metastases: neurosurgical routine or added value?Kaiyun Yang, Alexander P Landry, Majid Aljoghaiman, et al.
Current Oncology (Toronto, Ont.)|January 22, 2021
Clinicopathologic and Treatment Features of Long-Term Surviving Brain Metastasis PatientsArchya Dasgupta, Jayson Co, Jeff Winter, et al.
Paediatrics & Child Health|January 15, 2014
Social paediatrics: From 'lip service' to the health and well-being of Canada's children and youthDenis Daneman, James Kellner, Mark Bernstein, et al.
Neurosurgery|January 4, 2022
Importance of Cobalt-60 Dose Rate and Biologically Effective Dose on Local Control for Intracranial Meningiomas Treated With Stereotactic RadiosurgeryMichael Huo, Melanie Rose, Monique van Prooijen, et al.
Neuro-Oncology|January 29, 2014
Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomasNesrin Sabha, Christiane B Knobbe, Majula Maganti, et al.
Neurosurgery|April 14, 2025
Neoadjuvant Stereotactic Radiosurgery for Large Brain Metastases: An International, Multicenter, Single-Arm Phase II TrialRanda Higazy, Dianna Li, Ruth Lau, et al.
Pageof 30